Condition: Von Willebrand Disease (VWD) · Sponsor: University Hospital, Lille
WILL MANAGE is a prospective multicenter controlled open label randomized trial comparing an algorithm-based multidisciplinary management to a standard of care to reduce the incidence of bleeding (GI bleeding or severe epistaxis) recurrence in von Willebrand disease.
This description comes directly from the study's public registry record.
Marie Caillierez · 0033320444145 · DRC@chru-lille.Fr
Always discuss trial participation with your own doctor first.
| CHU Lille | Lille, Nord, France | Not Yet Recruiting |
| CHU Tours | Tours, Tours, France | Not Yet Recruiting |
| CHU Amiens | Amiens, France | Not Yet Recruiting |
| CHRU Brest | Brest, France | Not Yet Recruiting |
| Hôpital cardiologique Louis Pradel | Bron, France | Not Yet Recruiting |
| CHU Caen | Caen, France | Not Yet Recruiting |
| CH Chambery | Chambéry, France | Not Yet Recruiting |
| CHU Clermont-Ferrand | Clermont-Ferrand, France | Not Yet Recruiting |
| CHU Dijon | Dijon, France | Not Yet Recruiting |
| AP-HP Hôpital Kremlin Bicetre | Le Kremlin-Bicêtre, France | Not Yet Recruiting |
| AP-HM Hôpital Timone | Marseille, France | Not Yet Recruiting |
| CHU Montpellier | Montpellier, France | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06651255